Cyclopenthiazide
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | C03AA07 (WHO) |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | 742-20-1 |
PubChem (CID) | 2904 |
IUPHAR/BPS | 7899 |
ChemSpider | 2801 |
UNII | VX4S2N85F5 |
KEGG | D02061 |
ChEMBL | CHEMBL1373254 |
ECHA InfoCard | 100.010.920 |
Chemical and physical data | |
Formula | C13H18ClN3O4S2 |
Molar mass | 379.88 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(verify) |
Cyclopenthiazide (trade name Navidrex) is a thiazide diuretic used in the treatment of heart failure and hypertension.
Synthesis
Contraindications
Thiazide diuretics increase the excretion of sodium and potassium ions and decrease the excretion of calcium ions and uric acid so they are contraindicated in patients with hyponatraemia, hypokalaemia, hypercalcaemia and hyperuricaemia. They are also contraindicated in patients with Addison's disease.
See also
References
- ↑ Whitehead, C. W.; Traverso, J. J.; Sullivan, H. R.; Marshall, F. J. (1961). "Diuretics. V. 3,4-Dihydro-1,2,4-benzothiadiazine 1,1-Dioxides". The Journal of Organic Chemistry. 26 (8): 2814. doi:10.1021/jo01066a046.
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.